1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. IMMUNITYBIO INC
ImmunityBio Inc XNAS: IBRX
6.92 0.44 (6.79%)
95.6M

XNAS 21 Jan, 2026 4:30 PM (EST)

Watchlist

Portfolio

Alert

Regulatory Tailwinds
ImmunityBio rises on Tuesday as FDA clears approval path for its bladder cancer drug, ANKTIVA See details